Q4 2020 Holdings
Filed 2021-02-16 | 51 holdings | $67.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $28.5M | 1,627,500 | 42.4% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $15.2M | 319,000 | 22.6% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $10.7M | 139,000 | 15.9% |
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $6.5M | 578,500 | 9.7% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $3.6M | 110,000 | 5.4% |
| Aldeyra Therapeutics Inc(ALDX) | COM | 01438T106 | $1.3M | 192,500 | 2.0% |
| Annexon Inc(ANNX) | COM | 03589W102 | $626.0K | 25,000 | 0.9% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $489.0K | 6,000 | 0.7% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $22.1K | 255,800 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $20.8K | 637,500 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $18.5K | 863,100 | 0.0% |
| Mersana Therapeutics Inc | COM | 59045L106 | $18.5K | 694,000 | 0.0% |
| Vistagen Therapeutics Inc(VTGNUSD) | COM NEW | 92840H202 | $14.6K | 7,500,000 | 0.0% |
| Athira Pharma Inc | COM | 04746L104 | $13.5K | 393,000 | 0.0% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $13.1K | 283,500 | 0.0% |
| Trillium Therapeutics Inc | COM NEW | 89620X506 | $11.8K | 803,000 | 0.0% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $10.6K | 434,400 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $10.4K | 465,500 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | COM | 03753U106 | $9.6K | 167,054 | 0.0% |
| Bcls Acquisition Corp | COM CL A | G0904B105 | $9.4K | 842,500 | 0.0% |
| Surface Oncology Inc | COM | 86877M209 | $9.2K | 999,500 | 0.0% |
| Catalyst Biosciences Inc | COM NEW | 14888D208 | $8.6K | 1,357,500 | 0.0% |
| Iveric BIO Inc(OPHTEUR) | COM | 46583P102 | $8.4K | 1,212,500 | 0.0% |
| Fulcrum Therapeutics Inc(FULC) | COM | 359616109 | $8.0K | 682,500 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $7.9K | 207,500 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $7.6K | 164,800 | 0.0% |
| Concert Pharmaceuticals Inc(CNCEEUR) | COM | 206022105 | $6.8K | 537,500 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $6.3K | 246,200 | 0.0% |
| Jiya Acquisition Corp | COM CL A | 47760M102 | $5.8K | 562,500 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $5.7K | 92,500 | 0.0% |
| Verastem Inc | COM | 92337C104 | $5.1K | 2,400,000 | 0.0% |
| Health Sciences ACQ Corp 2 | ORD SHS | G4411D109 | $5.0K | 392,500 | 0.0% |
| Avadel Pharmaceuticals PLC | SPONSORED ADR | 05337M104 | $4.7K | 705,218 | 0.0% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $4.3K | 530,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN)Call | COM | G11196105 | $4.3K | 50,000 | 0.0% |
| Praxis Precision Medicines I | COM | 74006W108 | $4.2K | 75,645 | 0.0% |
| Rapt Therapeutics Inc(RAPTEUR) | COM | 75382E109 | $4.1K | 209,600 | 0.0% |
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $3.8K | 120,000 | 0.0% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $3.6K | 32,500 | 0.0% |
| Clearside Biomedical Inc(CLSDUSD) | COM | 185063104 | $3.4K | 1,250,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $1.9K | 330,000 | 0.0% |
| Oncorus Inc | COM | 68236R103 | $1.7K | 53,500 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.2K | 80,000 | 0.0% |
| Cyclacel Pharmaceuticals Inc | COM | 23254L603 | $1.2K | 150,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $1.1K | 20,000 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $923 | 15,000 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $846 | 107,500 | 0.0% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $829 | 20,000 | 0.0% |
| Karuna Therapeutics Inc | COM | 48576A100 | $508 | 5,000 | 0.0% |
| Panacea Acquisition Corp | *W EXP 07/07/202 | 698102118 | $299 | 93,332 | 0.0% |